Complementary Therapeutic Approaches: Mohs Micrographic Surgery and Immunotherapy in Non-Melanoma Skin Cancer
Saturday, May 6, 2023
3:00 PM Eastern
2:00 PM Central
1:00 PM Mountain
12:00 PM Pacific
Features:
- Online personalized quality-improvement poster-generation portal
- Downloadable animations
Learning Objectives
- Examine clinical trials data supporting the use of new systemic immunotherapy for the treatment of patients with advanced NMSCs failing or not amenable to surgery or radiation
- Describe risk-assessment of patients with NMSCs who may derive greater benefit from new systemic therapies as opposed to Mohs surgery
- Review the coordination and collaboration of multidisciplinary team members in the management of patients with advanced NMSCs failing or not amenable to surgery or radiation
Target Audience
This initiative is designed to meet the educational needs of surgical dermatologists, Mohs surgeons, dermatologists, and other healthcare practitioners who care for patients with advanced/mBCC or cSCC.
Accreditation Statement
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
Physician Credit Designation Statement
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
Joint Accreditation Statement
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 1.0 ANCC contact hour.
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosure Of Unlabeled Use
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Disclaimer
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to the live event at info@medlearninggroup.com
Release date: May 6, 2023
Expiration date: May 6, 2024
Estimated time to completion: 1.0 hour
